This inventor holds 1 USPTO granted patent. Top assignee: Korea Research Institute of Chemical Technology. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: A Reum Go: Innovator in Cancer Treatment
Introduction
A Reum Go is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cancer treatment methods. His innovative work focuses on the creation of a benzamide derivative that has potential applications in oncology.
Latest Patents
A Reum Go holds a patent for a benzamide derivative, which includes a preparation method and a pharmaceutical composition that utilizes this derivative as an active ingredient for the prevention or treatment of cancer. The invention is designed to suppress EGFR mutation, which is a common factor in various cancers. The benzamide derivative demonstrates a remarkable synergy effect on anticancer activity when used in combination with EGFR antagonists, such as Cetuximab. This advancement positions it as a promising candidate for use as an anticancer agent.
Career Highlights
A Reum Go is affiliated with the Korea Research Institute of Chemical Technology, where he continues to engage in research and development. His work is characterized by a commitment to improving cancer treatment options through innovative pharmaceutical solutions.
Collaborations
A Reum Go collaborates with Kwangho Lee, who is also involved in research related to cancer treatment. Their partnership enhances the potential for groundbreaking discoveries in the field.
Conclusion
A Reum Go's contributions to cancer treatment through his innovative benzamide derivative highlight the importance of research in pharmaceuticals. His work not only advances scientific knowledge but also offers hope for improved cancer therapies.